4.2 Article

Prospective study of clinical characteristics of melanoma patients with retinopathy caused by a high-dose interferon α-2b

Related references

Note: Only part of the references are listed.
Review Ophthalmology

Retinopathy of prematurity: a review of risk factors and their clinical significance

Sang Jin Kim et al.

SURVEY OF OPHTHALMOLOGY (2018)

Review Ophthalmology

An Update on Optical Coherence Tomography Angiography in Diabetic Retinopathy

Joobin Khadamy et al.

JOURNAL OF OPHTHALMIC & VISION RESEARCH (2018)

Article Gastroenterology & Hepatology

Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C

Ji-Hua Xue et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Ophthalmology

Is Combination Therapy Interferon and Ribavirin in Patients with Chronic Hepatitis C Infection Toxic for Eyes?

Nasser Mousa et al.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)

Article Dermatology

AJCC melanoma staging update: impact on dermatopathology practice and patient management

Adriano Piris et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2011)

Article Gastroenterology & Hepatology

Outcome of Retinopathy in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin

Nilesh Mehta et al.

DIGESTIVE DISEASES AND SCIENCES (2010)

Article Oncology

Final Version of 2009 AJCC Melanoma Staging and Classification

Charles M. Balch et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Ophthalmology

Interferon-associated retinopathy - a case report

I. Mantel et al.

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2007)

Review Rheumatology

Syndromes and complications of interferon therapy

Frances A. Y. Borg et al.

CURRENT OPINION IN RHEUMATOLOGY (2007)

Article Ophthalmology

Retinopathy associated with high-dose interferon alfa-2b therapy

C Hejny et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2001)